RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
Babies aged 0 to 90 days with a suspected infection requiring treatment with vancomycin will
be recruited. They will be randomised to receive vancomycin as an intermittent infusion (over
1 hour) or as a continuous infusion (over 24 hours). The hypothesis is that administering
vancomycin as a continuous infusion will result in improved attainment of target
concentrations in blood at steady state (when the drug is in equilibrium) compared to
intermittent infusion.
Phase:
N/A
Details
Lead Sponsor:
Murdoch Childrens Research Institute
Collaborators:
Mercy Hospital for Women, Australia Royal Children's Hospital Royal Hospital For Women